In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Actelion Pharmaceuticals takes 20.1% stake in EchoSense

Executive Summary

For CHF4.5mm ($5.1mm), Actelion Pharmaceuticals Ltd. (markets products for orphan diseases) has taken a 20.1% equity stake in Israeli device company EchoSense Ltd. This represents Actelion’s first major investment in devices.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
  • In Vitro Diagnostics
    • Therapeutic Drug Monitoring
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity

Related Companies